Nasopharyngeal carcinoma (NPC) is the tenth leading cancers in Taiwan and investigating its biomarker is important for understanding the mechanism of its pathogenesis.
NPC is the tenth leading cancers in Taiwan and investigating its biomarker is important for understanding the mechanism of its pathogenesis.
Study Type
OBSERVATIONAL
Enrollment
200
The difference of expression level of mucin glycosylating enzymes (by immunohistochemistry) in nasopharyngeal carcinoma and salivary gland tissues
Time frame: 1~5 years after patients received definite therapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.